WeLeader Biomedical Co., Ltd. (TPEX:7713)

WeLeader Biomedical Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	90.32	237.71	174.97	94.69	100.73	111.52
Short-Term Investments	74.24	97	34.37	7.83	8.4	4.18
Trading Asset Securities	32.41	-	2.83	2.43	2.33	3.01
Cash & Short-Term Investments	196.97	334.71	212.17	104.95	111.45	118.71
Cash Growth	-1.09%	57.76%	102.16%	-5.83%	-6.11%	-
Accounts Receivable	359.97	322.51	276.87	273.63	279.43	290.68
Other Receivables	1.43	-	-	0.05	0.1	1.03
Receivables	361.4	322.51	276.87	273.69	279.52	291.71
Inventory	129.96	117.93	99.06	69.67	62.73	55.89
Other Current Assets	8.43	5.23	3.21	2.11	1.02	2.11
Total Current Assets	696.76	780.39	591.32	450.42	454.73	468.42
Property, Plant & Equipment	1,152	1,589	1,341	1,194	1,086	351.66
Long-Term Investments	41.41	43.13	26.82	42.87	27.84	29.6
Other Intangible Assets	5.93	2.47	4.06	3.88	5.74	6.13
Long-Term Deferred Tax Assets	0.77	0.67	0.46	0.69	0.79	0.49
Other Long-Term Assets	623.84	33.5	34.63	36.02	25.24	26.8
Total Assets	2,520	2,449	1,998	1,728	1,600	883.09

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	224.08	214.45	183.54	143.19	155.28	160.65
Accrued Expenses	59.83	68.9	56.82	55.27	48.18	44.01
Short-Term Debt	-	-	80	57	121.03	53
Current Portion of Long-Term Debt	-	1.03	17.44	16.97	15.02	13.63
Current Portion of Leases	110.08	95.52	81.43	74.62	49.75	53.93
Current Income Taxes Payable	33.21	31.06	25.54	23.87	34.46	23.84
Current Unearned Revenue	5.39	5.2	1.52	0.34	0.7	1.95
Other Current Liabilities	16.05	16.15	22.71	30.43	14.13	12.81
Total Current Liabilities	448.64	432.3	469.01	401.69	438.54	363.81
Long-Term Debt	478.08	488.43	397.96	249.03	270.23	18.65
Long-Term Leases	390.79	268.14	219.94	228.38	245.22	142.99
Long-Term Deferred Tax Liabilities	0.01	-	-	-	-	0
Other Long-Term Liabilities	2.38	-	2.69	2.69	0.2	0.22
Total Liabilities	1,320	1,189	1,090	881.78	954.19	525.68

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	454.79	454.79	415.79	415.79	342.46	193.49
Additional Paid-In Capital	384.37	384.31	141.13	141.13	92.96	8.73
Retained Earnings	351.75	406.54	351.16	276.57	213.89	155.2
Comprehensive Income & Other	9.57	14.49	0.39	12.29	-3.01	-
Shareholders' Equity	1,200	1,260	908.47	845.78	646.3	357.41
Total Liabilities & Equity	2,520	2,449	1,998	1,728	1,600	883.09

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	978.95	853.11	796.77	626	701.25	282.19
Net Cash (Debt)	-781.98	-518.4	-584.6	-521.05	-589.79	-163.49
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-15.48	-11.16	-14.01	-12.68	-19.38	-5.82
Filing Date Shares Outstanding	45.48	45.48	41.58	41.59	34.25	27.88
Total Common Shares Outstanding	45.48	45.48	41.58	41.59	34.25	27.88
Working Capital	248.12	348.08	122.31	48.73	16.19	104.61
Book Value Per Share	26.40	27.71	21.85	20.34	18.87	12.82
Tangible Book Value	1,195	1,258	904.41	841.9	640.56	351.28
Tangible Book Value Per Share	26.27	27.65	21.75	20.24	18.70	12.60
Land	345.89	652.61	652.61	652.61	657.23	4.62
Buildings	232.24	-	-	-	11.93	11.93
Machinery	19.55	20.01	19.46	28.53	25.97	24.65
Construction In Progress	21.06	519.58	318.14	144.95	7.43	0.38

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 15, 2026

Data Sources Report a data error